Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Treasury Shares (2018 - 2025)

Aytu Biopharma (AYTU) has disclosed Treasury Shares for 8 consecutive years, with $4.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares fell 99.29% to $4.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 through Dec 2025, down 99.29% year-over-year, with the annual reading at $32912.0 for FY2025, 36.54% up from the prior year.
  • Treasury Shares for Q4 2025 was $4.0 at Aytu Biopharma, down from $31294.0 in the prior quarter.
  • The five-year high for Treasury Shares was $2.1 million in Q1 2022, with the low at $4.0 in Q4 2025.
  • Average Treasury Shares over 5 years is $225447.0, with a median of $30760.0 recorded in 2024.
  • The sharpest move saw Treasury Shares plummeted 100.0% in 2021, then soared 119579.79% in 2022.
  • Over 5 years, Treasury Shares stood at $33424.0 in 2021, then crashed by 75.57% to $8167.0 in 2022, then tumbled by 64.52% to $2898.0 in 2023, then crashed by 80.5% to $565.0 in 2024, then tumbled by 99.29% to $4.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $4.0, $31294.0, and $32912.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.